UK bill on new tissue and embryology authority: announcement soon:
This article was originally published in Clinica
An announcement concerning a draft bill to set up the UK's Regulatory Authority for Tissues and Embryology (RATE) is expected in November. The government intends that the new organisation will be responsible for regulating human tissue, gametes and embryos and will bring together the statutory functions that are currently the responsibility of the Human Tissue Authority and the Human Fertilisation and Embryology Authority (HFEA; see Clinica No 1227, p 15).
You may also be interested in...
Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.
US FDA’s ‘Project Renewal’ requires lots of work and flexibility, Oncology Center of Excellence acknowledges. Side-benefit may be getting outside physicians to appreciate the value of drug labeling.
The pharmaceutical industry would lose bid to eliminate PUPSIT but win relaxed WFI in proposed EU GMP Annex I revision.